SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
The appointment comes as SS Innovations continues to develop its proprietary SSi Mantra surgical robotic system and a comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. The company, an American company headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
Romano’s experience in raising capital and managing financial strategy in the medtech space is expected to be critical as SS Innovations seeks to bring its robotic system to the U.S. market. The company’s vision is to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population.
For more information, visit the company’s newsroom at https://ibn.fm/SSII.
